What is the address of Dokter Jan Debrauwere, cardioloog?

The registered office of Dokter Jan Debrauwere, cardioloog is located at Brusselsesteenweg 232, 1730 Asse.

Is Dokter Jan Debrauwere, cardioloog still active?

Yes. According to the CBE (30 September 2026) Dokter Jan Debrauwere, cardioloog is active, legal situation “Normale toestand”, started on 7 May 2010.

Is Dokter Jan Debrauwere, cardioloog registered on Peppol?

No, Dokter Jan Debrauwere, cardioloog is currently not registered on the Peppol network.

What is the enterprise number of Dokter Jan Debrauwere, cardioloog?

The enterprise number of Dokter Jan Debrauwere, cardioloog is BE0825761592.

When was Dokter Jan Debrauwere, cardioloog founded?

Dokter Jan Debrauwere, cardioloog was founded on 7 May 2010.

Who are the directors of Dokter Jan Debrauwere, cardioloog?

According to the 2025 annual accounts, the directors of Dokter Jan Debrauwere, cardioloog are: Jan Debrauwere.

Is Dokter Jan Debrauwere, cardioloog a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 May 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dokter Jan Debrauwere, cardioloog make in 2025?

Dokter Jan Debrauwere, cardioloog posted a profit after taxes of € 247,089 in financial year 2025.

What is the revenue of Dokter Jan Debrauwere, cardioloog?

As a small company, Dokter Jan Debrauwere, cardioloog is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 384,106.

Dokter Jan Debrauwere, cardioloog (Private Limited)

Dossier Dokter Jan Debrauwere, cardioloog, printed on 30 September 2026 from databakkes.be/en/0825761592/dokter-jan-debrauwere-cardioloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Dokter Jan Debrauwere, cardioloog from Asse, company number BE0825761592, closed financial year 2025 with a result of € 247,089 after tax. For that financial year Dokter Jan Debrauwere, cardioloog recorded a gross margin of € 384,106 and equity of € 972,235. Compared with financial year 2024, the result moved from € 221,665 to € 247,089. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.

What it is worth Healthy

€ 972,235

▼ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 247,089

▲ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 203,889

▲ 107% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 312,188 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 24,564

▼ 51% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 169,994

▲ € 127,880 vs 2024

€ 71,710 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 2,008

▼ 86% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 60,936

▼ 50% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 360,928 Gross margin 2022: € 360,928 First fiscal year in the series	€ 432,843 Gross margin 2023: € 432,843 ▲ 20% vs 2022 (€ 360,928) Favourable step	€ 345,802 Gross margin 2024: € 345,802 ▼ 20% vs 2023 (€ 432,843) Unfavourable step	€ 384,106 Gross margin 2025: € 384,106 ▲ 11% vs 2024 (€ 345,802) Favourable step	▲ 11%
Profit after taxes	€ 202,509 Profit after taxes 2022: € 202,509 First fiscal year in the series	€ 291,461 Profit after taxes 2023: € 291,461 ▲ 44% vs 2022 (€ 202,509) Favourable step	€ 221,665 Profit after taxes 2024: € 221,665 ▼ 24% vs 2023 (€ 291,461) Unfavourable step	€ 247,089 Profit after taxes 2025: € 247,089 ▲ 11% vs 2024 (€ 221,665) Favourable step	▲ 11%
Equity	€ 759,981 Equity 2022: € 759,981 First fiscal year in the series	€ 986,462 Equity 2023: € 986,462 ▲ 30% vs 2022 (€ 759,981) Favourable step	€ 1,037,335 Equity 2024: € 1,037,335 ▲ 5% vs 2023 (€ 986,462) Favourable step	€ 972,235 Equity 2025: € 972,235 ▼ 6% vs 2024 (€ 1,037,335) Unfavourable step	▼ 6%
Total debts	€ 152,126 Total debts 2022: € 152,126 First fiscal year in the series	€ 168,580 Total debts 2023: € 168,580 ▲ 11% vs 2022 (€ 152,126) Unfavourable step	€ 180,131 Total debts 2024: € 180,131 ▲ 7% vs 2023 (€ 168,580) Unfavourable step	€ 239,169 Total debts 2025: € 239,169 ▲ 33% vs 2024 (€ 180,131) Unfavourable step	▲ 33%
Cash	€ 111,371 Cash 2022: € 111,371 First fiscal year in the series	€ 188,107 Cash 2023: € 188,107 ▲ 69% vs 2022 (€ 111,371) Favourable step	€ 98,610 Cash 2024: € 98,610 ▼ 48% vs 2023 (€ 188,107) Unfavourable step	€ 203,889 Cash 2025: € 203,889 ▲ 107% vs 2024 (€ 98,610) Favourable step	▲ 107%
Retained profit	€ 741,381 Retained profit 2022: € 741,381 First fiscal year in the series	€ 967,862 Retained profit 2023: € 967,862 ▲ 31% vs 2022 (€ 741,381) Favourable step	€ 1,018,735 Retained profit 2024: € 1,018,735 ▲ 5% vs 2023 (€ 967,862) Favourable step	€ 953,635 Retained profit 2025: € 953,635 ▼ 6% vs 2024 (€ 1,018,735) Unfavourable step	▼ 6%
Dividend	€ 118,803 Dividend 2022: € 118,803 First fiscal year in the series	€ 64,979 Dividend 2023: € 64,979 ▼ 45% vs 2022 (€ 118,803) Unchanged	€ 170,793 Dividend 2024: € 170,793 ▲ 163% vs 2023 (€ 64,979) Unchanged	€ 312,188 Dividend 2025: € 312,188 ▲ 83% vs 2024 (€ 170,793) Unchanged	▲ 83%
Bank debt	€ 89,617 Bank debt 2022: € 89,617 First fiscal year in the series	€ 65,948 Bank debt 2023: € 65,948 ▼ 26% vs 2022 (€ 89,617) Favourable step	€ 42,113 Bank debt 2024: € 42,113 ▼ 36% vs 2023 (€ 65,948) Favourable step	€ 169,994 Bank debt 2025: € 169,994 ▲ € 127,880 vs 2024 (€ 42,113) Unfavourable step	▲ € 127,880
Balance sheet total	€ 912,107 Balance sheet total 2022: € 912,107 First fiscal year in the series	€ 1,155,043 Balance sheet total 2023: € 1,155,043 ▲ 27% vs 2022 (€ 912,107) Unchanged	€ 1,217,466 Balance sheet total 2024: € 1,217,466 ▲ 5% vs 2023 (€ 1,155,043) Unchanged	€ 1,211,405 Balance sheet total 2025: € 1,211,405 Unchanged (€ 1,217,466) Unchanged

Key figures of Dokter Jan Debrauwere, cardioloog, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dokter Jan Debrauwere, cardioloog?

What happened at Dokter Jan Debrauwere, cardioloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2026 New annual accounts for financial year 2025: profit of € 247,089 (▲ 11% vs 2024). filed late Source: NBB ↗
May 7, 2010 New establishment in Asse. KBO
May 7, 2010 Start of the company according to the CBE. KBO
2010 Jan Debrauwere became a director. NBB

In short

From € 202,509 profit in 2022 to € 247,089 profit in 2025.

Paid € 451,031 in corporate taxes since 2022.

Best year ever: 2023, with € 291,461 profit.

Paid out € 666,763 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dokter Jan Debrauwere, cardioloog? We notify you, reason included.

Follow Dokter Jan Debrauwere, cardioloog

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jan Debrauwere

Dokter Jan Debrauwere, cardioloog

Behind Dokter Jan Debrauwere, cardioloog is Jan Debrauwere.

See the full network in the app

Directors

According to the 2025 annual accounts

Jan Debrauwere

Director

since 2010

Establishments

Establishment units

Physical locations of this company

Registered office

Brusselsesteenweg 232

1730 Asse

2.189.564.766

Brusselsesteenweg 332

1730 Asse

Active since 7 May 2010

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

VERENIGING VAN MEDEEIGENAARS GEBOUW WALFEY'S TE ASSE-WALVERGEM, BRUSSELSESTEENWEG 232

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0825.761.592
VAT number: BE 0825.761.592
Registered office: Brusselsesteenweg 232, 1730 Asse
Names & denominations: Dokter Jan Debrauwere, cardioloog
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 May 2010
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗